Adasuve
NDC 51097-001, loxapine, aerosol, powder, from Alexza Pharmaceuticals, Inc..
- Product NDC
- 51097-001
- Status
- Listed
- Labeler
- Alexza Pharmaceuticals, Inc.
- Dosage form
- AEROSOL, POWDER
- Route
- RESPIRATORY (INHALATION)
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022549
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51097-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LOXAPINE10 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51097-001-02 | 51097000102 | 5 INHALER in 1 CARTON (51097-001-02) / 1 AEROSOL, POWDER in 1 INHALER (51097-001-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/50e11732-7387-452d-b3e6-db3a431d5c4a
Use it
Look up 51097-001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51097-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51097-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.